Clinical Trial Update: Clinical Study to Assess Safety, PK and PD Parameters of CDR132L [Phase 1]

View source ↗

Summary

Cardior Pharmaceuticals completed a Phase 1 study assessing the safety, pharmacokinetics and pharmacodynamics of CDR132L in patients with heart failure. The sni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• CDR132L

Snippet

Sponsor: Cardior Pharmaceuticals GmbH | Conditions: Heart Failure | Phase 1 | Status: COMPLETED